Literature DB >> 3923837

Prevalence and manifestations of endometritis among women with cervicitis.

J Paavonen, N Kiviat, R C Brunham, C E Stevens, C C Kuo, W E Stamm, A Miettinen, M Soules, D A Eschenbach, K K Holmes.   

Abstract

Thirty-five women referred from a clinic treating sexually transmitted diseases, because of suspected cervicitis, were studied for the presence of endometritis by transcervical endometrial biopsies and cervical and endometrial cultures. Fourteen (40%) of the patients had histologic evidence of endometritis. Findings that significantly correlated with endometritis included a history of intermenstrual vaginal bleeding, the presence of Chlamydia trachomatis, Neisseria gonorrhoeae, or Streptococcus agalactiae in the cervix, and the presence of serum antibodies to C. trachomatis or to Mycoplasma hominis.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3923837     DOI: 10.1016/s0002-9378(85)80210-6

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  16 in total

1.  Pelvic inflammatory disease: a family practice perspective.

Authors:  J W Sellors
Journal:  Can Fam Physician       Date:  1989-06       Impact factor: 3.275

2.  Localization of Chlamydia trachomatis heat shock proteins 60 and 70 during infection of a human endometrial epithelial cell line in vitro.

Authors:  J E Raulston; T R Paul; S T Knight; P B Wyrick
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

Review 3.  [Inflammations of the lower genital tract].

Authors:  N Pavić
Journal:  Arch Gynecol Obstet       Date:  1987       Impact factor: 2.344

4.  Nongonococcal and Nonchlamydial Cervicitis.

Authors:  Paul Nyirjesy
Journal:  Curr Infect Dis Rep       Date:  2001-12       Impact factor: 3.725

5.  Screening for chlamydial infection. Taking stock.

Authors:  J W Sellors
Journal:  Can Fam Physician       Date:  1995-02       Impact factor: 3.275

Review 6.  Drug therapies for sexually transmitted diseases. Clinical and economic considerations.

Authors:  W R Bowie
Journal:  Drugs       Date:  1995-04       Impact factor: 9.546

7.  Cost-effectiveness analysis of Chlamydia trachomatis screening via internet-based self-collected swabs compared with clinic-based sample collection.

Authors:  Wei Huang; Charlotte A Gaydos; Mathilda R Barnes; Mary Jett-Goheen; Diane R Blake
Journal:  Sex Transm Dis       Date:  2011-09       Impact factor: 2.830

8.  Comparative effectiveness of a rapid point-of-care test for detection of Chlamydia trachomatis among women in a clinical setting.

Authors:  Wei Huang; Charlotte A Gaydos; Mathilda R Barnes; Mary Jett-Goheen; Diane R Blake
Journal:  Sex Transm Infect       Date:  2012-09-14       Impact factor: 3.519

Review 9.  General practice update: chlamydia infection in women.

Authors:  P Oakeshott; P Hay
Journal:  Br J Gen Pract       Date:  1995-11       Impact factor: 5.386

10.  Cost-effectiveness of screening strategies for Chlamydia trachomatis using cervical swabs, urine, and self-obtained vaginal swabs in a sexually transmitted disease clinic setting.

Authors:  Diane R Blake; Nancy Maldeis; Mathilda R Barnes; Andrew Hardick; Thomas C Quinn; Charlotte A Gaydos
Journal:  Sex Transm Dis       Date:  2008-07       Impact factor: 2.830

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.